Vaccine Therapy With or Without Sargramostim in Treating Patients With Stage IIB, Stage IIC, Stage III, or Stage IV Melanoma
Clinical trial NCT00089193 · COMPLETED
Trial details
- NCT number
- NCT00089193
- Sponsor
- Craig L Slingluff, Jr
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2003-09-01
- Primary completion
- 2007-02-01
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.